"paper"

In this paper, the authors report a patient treated with natalizumab for relapsing-remitting MS who developed COVID-19 and recovered in a few days without complications.

In this paper published in Neurology, the authors conducted a scoping review of available literature on COVID-19 to assess the potential impact on neurologists in terms of prevalent comorbidities and incidence of new neurological events in patients hospitalized with COVID-19.

n this paper recently published in JAMA, the authors evaluated the prevalence, intensity, and timing of an altered sense of smell or taste in mildly symptomatic patients with SARS-CoV-2 infection.

In this paper recently published in Movement Disorders, Prasad et al., surveyed the perceptions of 100 patients with Parkinson’s disease (PD) and their caregivers who were under follow-up at the National Institute of Mental Health and Neurosciences, Bengaluru, India on the implications of Covid-19 infection.

In this paper recently published in Movement Disorders, Antonini et al., report the outcome of 10 clinical cases of Parkinson’s Disease patients infected by SARS-CoV-2, collected from the experience at the Parkinson and Movement Disorders Unit in Padua, Italy and the Parkinson’s Foundation Centre of Excellence at King’s College Hospital in London, UK.

In this paper, Baracchini et al., share their single-center experience of the substantial changes in the acute stroke management pathway during the COVID-19 outbreak.

In this paper recently published in the Journal of Neurology, Neurosurgery, and Psychiatry, the authors describe the demographic, clinical, radiological and laboratory characteristics of six consecutive patients assessed between 1st and 16th April 2020 at the National Hospital for Neurology and Neurosurgery, Queen Square, London, UK

In this paper recently published in The New England Journal of Medicine, Oxley et al., report five cases of large-vessel stroke in patients younger than 50 years of age affected by SARS-CoV-2 infection.

In this very useful paper, the European Society of Minimally Invasive Neurological Therapy (ESMINT) gives recommendations for optimal interventional neurovascular management during the covid-19 outbreak. The authors identify some important priorities including: early detection and limiting exposure of healthcare workers… Continue Reading

It has been already reported that COVID-19 infection may predispose patients to thrombotic disease, both in the venous and arterial circulations, due to excessive inflammation, platelet activation, endothelial dysfunction, and stasis. In addition, many patients receiving antithrombotic therapy for thrombotic… Continue Reading

In this report, the authors examined five patients who had Guillain–Barré syndrome after the onset of coronavirus disease 2019 (Covid-19) infection. Four of the patients had a positive nasopharyngeal swab for SARS-CoV-2 at the onset of the neurologic syndrome, while… Continue Reading

COVID-19 AND NEUROLOGY In this useful consensus paper, the current clinical guidelines and research progress on the management of COVID-19 are summarized, emphasizing on its neurological manifestations.  The aim of consensus was to help neurologists to understand the occurrence, development… Continue Reading

In a case series of 214 patients with coronavirus disease 2019 (COVID-19) Mao et al., report that neurologic symptoms were seen in 36.4% of patients and were more common in patients with severe infection (45.5%) according to their respiratory status.… Continue Reading